- Editor's PickYahoo Finance•2 days ago
Prominent short-seller Jim Chanos, the founder of Kynikos Associates, says there are seven things he looks at when making a short bet. Chanos achieved legendary status for his bet against Enron as it was later revealed to be a fraud. “At Valeant and Enron, the CEOs in the situation fit six or seven — innovation like no other, larger-than-life CEO, and complaint board… We keep an eye on these kinds of things,” Chanos said at the Vanity Fair New Establishment Summit in San Francisco on Wednesday.
Pershing Square Holdings’ latest performance disclosure shows that it’s down 22.2% in 2016. Ackman is facing the possibility of the fund being down by more than 20% for the second straight year.
Valeant Pharmaceuticals International, Inc. (VRX)
NYSE - NYSE Real Time Price. Currency in USD
|Bid||22.20 x 3400|
|Ask||22.25 x 300|
|Day's Range||21.90 - 22.45|
|52wk Range||18.55 - 127.08|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||-7.52|
|Avg Vol (3m)||21,161,250|
|Dividend & Yield||0.00 (0.00%)|